Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 240

Sort by

Sort Order Select

Journal Articles

YAP1 regulates thrombopoiesis by binding to MYH9 in immune thrombocytopenia

Shuhong Hu, Yifei Liu, Xiang Zhang, Xiaoqi Wang, Yanting Li, Mengqian Chu, Jie Yin, Yanglan Fang, Changgeng Ruan, Li Zhu, Depei Wu, Yang Xu

Blood (2024) 144 (20): 2136–2148.

https://doi.org/10.1182/blood.2023023601

Published: 2024

Includes: Supplemental data

Journal Articles

Selective Histone Deacetylase Inhibitor Chidamide in Steroid Refractory Chronic Graft-Versus-Host Disease

Kangkang Lv, Yuejun Liu, Xuefeng He, Mingzhu Xu, Yuanyuan Du, Mimi Xu, Yue Han, Depei Wu

Blood (2024) 144 (Supplement 1): 7348.

https://doi.org/10.1182/blood-2024-209598

Published: 2024

Journal Articles

Efficacy and Safety of Venetoclax in Combination with Hypomethylating Agents for the Treatment of High-Risk Myelodysplastic Syndromes–Real-World Analyses

Jian Zhang, Yang Xu, Zhihong Lin, Jun Chen, Limin Liu, Depei Wu, Huiying Qiu

Blood (2024) 144 (Supplement 1): 6732.

https://doi.org/10.1182/blood-2024-199990

Published: 2024

Journal Articles

Large-Scale Metabolomic Mendelian Randomization Analysis Identifies Pyridoxate As a Key Factor in Graft-Versus-Host Disease

Xinghao Yu, Yiyin Chen, Lei Lei, Dandan Lin, Ying Shen, Chang Hou, Jia Chen, Yi Fan, Huimin Lu, Depei Wu, Yang Xu

Blood (2024) 144 (Supplement 1): 3523.

https://doi.org/10.1182/blood-2024-206745

Published: 2024

Journal Articles

Short-Term Blinatumomab Prior to Allo-HSCT for High-Risk B-ALL

Huizhu Kang, Yuejun Liu, Ruju Wang, Meng Zhou, Chengyuan Gu, Xuefeng He, Jun Chen, Zhihong Lin, Depei Wu, Yue Han

Blood (2024) 144 (Supplement 1): 3494.

https://doi.org/10.1182/blood-2024-208142

Published: 2024

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation in Natural Killer/T-Cell Lymphoma: A Retrospective Analysis of the EBMT Lymphoma Working Party

Blood (2024) 144 (Supplement 1): 3070.

https://doi.org/10.1182/blood-2024-207545

Published: 2024

Journal Articles

In AML Patients Allografted in First Remission, DNMT3A Mutations Differentially Affect Post-Transplant Outcomes According to Karyotype, NPM1 and FLT3-ITD Mutation Status - from the EBMT-ALWP

Blood (2024) 144 (Supplement 1): 4315.

https://doi.org/10.1182/blood-2024-202764

Published: 2024

Journal Articles

5-Year Follow-up of Combined Infusion of Anti-CD19 and Anti-BCMA CAR-T after ASCT for High-Risk Newly Diagnosed Multiple Myeloma

Xiaolan Shi, Chengcheng Fu, Lingzhi Yan, Yingying Zhai, Zhi Yan, Jingjing Shang, Song Jin, Xingyue Wu, Hongying You, Shuang Yan, Weiqin Yao, Liqing Kang, Lei Yu, Depei Wu

Blood (2024) 144 (Supplement 1): 4766.

https://doi.org/10.1182/blood-2024-207687

Published: 2024

Journal Articles

Glofitamab Combined with Salvage Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Real-World Prospective Observational Study in Chinese Patients

Jingxian Gu, Tao You, Peng Xu, Jiebing Xiao, Wei Dai, Zhengming Jin, Xiao Ma, Depei Wu, Haiwen Huang

Blood (2024) 144 (Supplement 1): 6530.

https://doi.org/10.1182/blood-2024-203283

Published: 2024

Journal Articles

Construction and Validation of the New Prognostic Model Based on Genetic Risk Stratification for Chinese AML Patients

Fengli Li, Yangyang Ding, Shanglong Feng, Beibei Xie, Xunyi Jiao, Jinli Zhu, Qing Zhang, Qianshan Tao, Huiping Wang, Xin Liu, Depei Wu, Zhimin Zhai

Blood (2024) 144 (Supplement 1): 6164.

https://doi.org/10.1182/blood-2024-210615

Published: 2024

Journal Articles

Chemotherapy-Free Treatment with Venetoclax, Azacitidine and Flumatinib Induces an Early and Deep Molecular Response in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia：What Is the Underlying Mechanism?

Lingling Liu, Mengyun Li, Qingya Cui, Yangzi Li, Li Yao, Jianxin Fu, Depei Wu, Xiaowen Tang

Blood (2024) 144 (Supplement 1): 5915.

https://doi.org/10.1182/blood-2024-206869

Published: 2024

Journal Articles

MRD Evaluation in a Transplant-Eligible NDMM Study

Yuhe Peng, Chengcheng Fu, Song Jin, Jingjing Shang, Weiqin Yao, Zhi Yan, Yingying Zhai, Li Yao, Hongmiao Shen, Xingyue Wu, Hongying You, Yue Huang, Jing Wang, Jiao Lu, Depei Wu

Blood (2024) 144 (Supplement 1): 6995.

https://doi.org/10.1182/blood-2024-207983

Published: 2024

Journal Articles

Real World Analysis of the Efficacy, Prognosis and Safety of Daratumumab, Carfilzomib, and Dexamethasone (DKD) in Relapsed or Refractory Multiple Myeloma Patients

Chengcheng Fu, Hongying You, Song Jin, Panfeng Wang, Lingzhi Yan, Liying Zhang, Tingting Lu, Xiao Gao, Lei Jiang, Hongchun Qiu, Jingjing Shang, Yingying Zhai, Weiqin Yao, Shuang Yan, Zhi Yan, Depei Wu

Blood (2024) 144 (Supplement 1): 6992.

https://doi.org/10.1182/blood-2024-210102

Published: 2024

Journal Articles

Ixazomib Based Regimens As Front-Line Treatment in Newly Diagnosed Multiple Myeloma Patients in China: A Real-World Data from Infinite Study

Fu Cheng Cheng, Song Jin, Junling Zhuang, Xin Zhou, Fan Zhou, Yuhua Li, Kaiyang Ding, Ting Niu, Wenming Chen, Baijun Fang, Li-Li Chen, Rong Fu, Hao Zhang, Jiaping Fu, Xiuju Wang, Sha Liu, Lin Li, Depei Wu

Blood (2024) 144 (Supplement 1): 6970.

https://doi.org/10.1182/blood-2024-204366

Published: 2024

Journal Articles

Pomalidomide, Rituximab, Orelabrutinib, and Minichop-like (PRO-miniCHOP) in Elderly Patients with Newly Diagnosed Diffuse Large-B Cell Lymphoma: Updated Results from a Phase II Study

Nana Ping, Changju Qu, Jiajie He, Hailing Liu, Rui Zou, Qian Zhu, Xiao Zhang, Depei Wu, Zhengming Jin

Blood (2024) 144 (Supplement 1): 6479.

https://doi.org/10.1182/blood-2024-198588

Published: 2024

Journal Articles

A Multicenter Prospective Clinical Study of Venetoclax Combined with Azactidine in the Treatment of Newly Diagnosed Acute Leukaemias of Ambiguous Lineage: Interim Analysis of a Phase 2 Trial

Si-Man Huang, Tong-Tong Zhang, Lan Dai, Chao-Ling Wan, Han-Yu Cao, Hai-Ping Dai, Ming-Zhu Xu, Depei Wu, Sheng-Li Xue

Blood (2024) 144 (Supplement 1): 5899.

https://doi.org/10.1182/blood-2024-204660

Published: 2024

Journal Articles

Subcutaneous Abatacept for Acute Graft-Versus-Host Disease Prophylaxis after Haploidentical Donor Hematopoietic Cell Transplantation: Efficacy, Safety, and Immunologic Effects

Yuhua Ru, Jinjin Zhu, Huanle Gong, Mimi Xu, Ying Wang, Miao Miao, Suning Chen, Xiang Zhang, Yi Fan, Yang Xu, Jia Chen, Depei Wu

Blood (2024) 144 (Supplement 1): 3515.

https://doi.org/10.1182/blood-2024-202490

Published: 2024

Journal Articles

VA Combined with Mbucy Conditioning Regimen Followed By Allo-HSCT Can Improve Survival of High-Risk AML Patients: A Prospective, Single-Center, Single-Arm Clinical Trial

Wei Cui, Xiaoqian Chen, Qingya Cui, Zheng Li, Sifan Chen, Mengyun Li, Xuekai Li, Juan Chen, Yan Yu, Depei Wu, Xiaowen Tang

Blood (2024) 144 (Supplement 1): 3493.

https://doi.org/10.1182/blood-2024-207083

Published: 2024

Journal Articles

Autologous Fecal Microbiota Transplantation As a Gvhd Prophylaxis in Patients with Haploidentical Hematopoietic Stem Cell Transplantation: A Prospective, Randomized Trial

Yin Liu, Ye Zhao, Xiaofei Qi, Qiao Cheng, Jia Chen, Xiao Ma, Shengli Xue, Ying Wang, Xiaowen Tang, Huiying Qiu, Yang Xu, Depei Wu

Blood (2024) 144 (Supplement 1): 3535.

https://doi.org/10.1182/blood-2024-209696

Published: 2024

Journal Articles

Challenging the Adverse Label: Diverse Outcomes of ELN 2022 Adverse Cytogenetic Subgroups in Acute Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation in First Remission: On Behalf of the EBMT Acute Leukemia Working Party

Blood (2024) 144 (Supplement 1): 851.

https://doi.org/10.1182/blood-2024-201380

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

YAP1 regulates thrombopoiesis by binding to MYH9 in immune thrombocytopenia

Selective Histone Deacetylase Inhibitor Chidamide in Steroid Refractory Chronic Graft-Versus-Host Disease

Efficacy and Safety of Venetoclax in Combination with Hypomethylating Agents for the Treatment of High-Risk Myelodysplastic Syndromes–Real-World Analyses

Large-Scale Metabolomic Mendelian Randomization Analysis Identifies Pyridoxate As a Key Factor in Graft-Versus-Host Disease

Short-Term Blinatumomab Prior to Allo-HSCT for High-Risk B-ALL

Autologous Hematopoietic Stem Cell Transplantation in Natural Killer/T-Cell Lymphoma: A Retrospective Analysis of the EBMT Lymphoma Working Party

In AML Patients Allografted in First Remission, DNMT3A Mutations Differentially Affect Post-Transplant Outcomes According to Karyotype, NPM1 and FLT3-ITD Mutation Status - from the EBMT-ALWP

5-Year Follow-up of Combined Infusion of Anti-CD19 and Anti-BCMA CAR-T after ASCT for High-Risk Newly Diagnosed Multiple Myeloma

Glofitamab Combined with Salvage Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Real-World Prospective Observational Study in Chinese Patients

Construction and Validation of the New Prognostic Model Based on Genetic Risk Stratification for Chinese AML Patients

Chemotherapy-Free Treatment with Venetoclax, Azacitidine and Flumatinib Induces an Early and Deep Molecular Response in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia：What Is the Underlying Mechanism?

MRD Evaluation in a Transplant-Eligible NDMM Study

Real World Analysis of the Efficacy, Prognosis and Safety of Daratumumab, Carfilzomib, and Dexamethasone (DKD) in Relapsed or Refractory Multiple Myeloma Patients

Ixazomib Based Regimens As Front-Line Treatment in Newly Diagnosed Multiple Myeloma Patients in China: A Real-World Data from Infinite Study

Pomalidomide, Rituximab, Orelabrutinib, and Minichop-like (PRO-miniCHOP) in Elderly Patients with Newly Diagnosed Diffuse Large-B Cell Lymphoma: Updated Results from a Phase II Study

A Multicenter Prospective Clinical Study of Venetoclax Combined with Azactidine in the Treatment of Newly Diagnosed Acute Leukaemias of Ambiguous Lineage: Interim Analysis of a Phase 2 Trial

Subcutaneous Abatacept for Acute Graft-Versus-Host Disease Prophylaxis after Haploidentical Donor Hematopoietic Cell Transplantation: Efficacy, Safety, and Immunologic Effects

VA Combined with Mbucy Conditioning Regimen Followed By Allo-HSCT Can Improve Survival of High-Risk AML Patients: A Prospective, Single-Center, Single-Arm Clinical Trial

Autologous Fecal Microbiota Transplantation As a Gvhd Prophylaxis in Patients with Haploidentical Hematopoietic Stem Cell Transplantation: A Prospective, Randomized Trial

Challenging the Adverse Label: Diverse Outcomes of ELN 2022 Adverse Cytogenetic Subgroups in Acute Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation in First Remission: On Behalf of the EBMT Acute Leukemia Working Party

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only